Brief: Shenzhen Neptunus Interlong Bio-Technique Says Unit Entered Agreement With Neptunus Bio-Engineering
10/01/2020 13:53
Jan 10 (Reuters) - Shenzhen Neptunus Interlong Bio-technique
Co Ltd 8329.HK :
* UNIT ENTERED INTO SALES FRAMEWORK AGREEMENT WITH NEPTUNUS
BIO-ENGINEERING
* UNDER DEAL, NEPTUNUS BIO-ENGINEERING GROUP AGREED TO
PURCHASE
PREFILLED CATHETER FLUSHERS
Source text for Eikon: ID:nHKS6Zc5GH
Further company coverage: 8329.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million